EGFR and gastric adenocarcinoma: One PR was observed in a gastric adenocarcinoma patient who failed 2 lines of chemotherapy and 1 VEGFR2 TKI; however, the tumor tissue from biopsy was not enough to assess EGFR and HER2 status.